RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $248,486,000 | +4.4% | 210,582 | 0.0% | 0.00% | – |
| Q2 2022 | $237,957,000 | -62.2% | 210,582 | 0.0% | 0.00% | – |
| Q1 2022 | $629,640,000 | +12.8% | 210,582 | 0.0% | 0.00% | – |
| Q4 2021 | $558,042,000 | -27.0% | 210,582 | 0.0% | 0.00% | – |
| Q3 2021 | $764,413,000 | -42.2% | 210,582 | -30.9% | 0.00% | -100.0% |
| Q2 2021 | $1,321,986,000 | +27.4% | 304,605 | +0.4% | 0.00% | – |
| Q1 2021 | $1,037,588,000 | -3.1% | 303,388 | -0.8% | 0.00% | -100.0% |
| Q4 2020 | $1,070,364,000 | +369.7% | 305,818 | +222.1% | 0.00% | – |
| Q3 2020 | $227,879,000 | +16.7% | 94,950 | -11.0% | 0.00% | – |
| Q2 2020 | $195,272,000 | +15.2% | 106,706 | -1.8% | 0.00% | – |
| Q1 2020 | $169,504,000 | -10.1% | 108,656 | +23.4% | 0.00% | – |
| Q4 2019 | $188,480,000 | +7.4% | 88,075 | -6.2% | 0.00% | – |
| Q3 2019 | $175,554,000 | -18.7% | 93,879 | +13.4% | 0.00% | – |
| Q2 2019 | $216,001,000 | +40.2% | 82,759 | +38.0% | 0.00% | – |
| Q1 2019 | $154,087,000 | +11.7% | 59,956 | 0.0% | 0.00% | – |
| Q4 2018 | $137,899,000 | -28.3% | 59,956 | 0.0% | 0.00% | – |
| Q3 2018 | $192,459,000 | +13.4% | 59,956 | 0.0% | 0.00% | – |
| Q2 2018 | $169,675,000 | -26.8% | 59,956 | -8.4% | 0.00% | – |
| Q1 2018 | $231,810,000 | +121.3% | 65,483 | +142.5% | 0.00% | – |
| Q4 2017 | $104,760,000 | +67053.8% | 27,000 | -64.0% | 0.00% | – |
| Q1 2016 | $156,000 | -97.0% | 75,000 | -95.7% | 0.00% | -100.0% |
| Q4 2015 | $5,288,000 | +9.6% | 1,745,143 | -10.7% | 0.01% | +20.0% |
| Q3 2015 | $4,827,000 | -23.1% | 1,954,300 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $6,273,000 | -10.1% | 1,954,300 | 0.0% | 0.01% | -14.3% |
| Q1 2015 | $6,977,000 | +57.3% | 1,954,300 | 0.0% | 0.01% | +75.0% |
| Q4 2014 | $4,436,000 | +15.1% | 1,954,300 | -1.6% | 0.00% | 0.0% |
| Q3 2014 | $3,854,000 | -44.1% | 1,986,396 | +4.5% | 0.00% | -42.9% |
| Q2 2014 | $6,898,000 | -6.4% | 1,900,196 | 0.0% | 0.01% | -12.5% |
| Q1 2014 | $7,373,000 | +36.1% | 1,900,196 | 0.0% | 0.01% | +33.3% |
| Q4 2013 | $5,416,000 | -20.4% | 1,900,196 | 0.0% | 0.01% | -25.0% |
| Q3 2013 | $6,803,000 | +39.0% | 1,900,196 | +29.7% | 0.01% | +33.3% |
| Q2 2013 | $4,895,000 | – | 1,465,596 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |